Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

ST7 Inhibitors

The primary mechanism through which ST7 inhibitors operate involves modulating chromatin structure and DNA accessibility, thereby affecting the regulatory functions of ST7 in gene expression. This modulation of chromatin structure, achieved by influencing enzymes responsible for chromatin remodeling, can change the transcriptional activity of genes under the regulatory umbrella of ST7. By altering the chromatin landscape, these inhibitors can influence the transcriptional dynamics and affect the pathways where ST7 exerts its tumor suppressive functions. The influence on chromatin structure can lead to changes in gene expression patterns, impacting the regulatory roles played by ST7.

These inhibitors target a variety of enzymes and processes that are integral to chromatin remodeling and gene expression regulation. By affecting histone acetylation and methylation, these compounds can alter the transcriptional landscape, impacting ST7's role in tumor suppression. The changes in histone modification patterns, brought about by these inhibitors, can lead to alterations in the accessibility of DNA to transcription factors and other regulatory proteins, thus influencing the gene expression profiles relevant to ST7's function. Additionally, some of these compounds bind directly to DNA, impacting the transcriptional processes and influencing the regulatory roles of ST7. The overarching effect of these inhibitors is to modulate the cellular environment in which ST7 operates, thereby influencing its ability to regulate gene expression and maintain cellular homeostasis. It's important to note that the specific effects of these inhibitors on ST7 are subject to research and are not confined to a narrow pathway. The complex nature of tumor suppressor gene regulation and the broad effects of these inhibitors on chromatin and gene expression make their specific impact on ST7 a subject of ongoing scientific inquiry. These compounds, by targeting processes fundamental to gene expression and chromatin structure, present a method to influence the regulatory environment of ST7, thereby affecting its role in cellular processes.

SEE ALSO...

Items 1 to 10 of 18 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Histone deacetylase inhibitor; could possibly inhibit ST7 by altering chromatin structure and affecting gene expression related to its tumor suppressive functions.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$30.00
$87.00
$132.00
$434.00
13
(1)

Simvastatin is a statin that inhibits HMG-CoA reductase, a key enzyme in the cholesterol biosynthesis pathway. This could possibly inhibit ST7 function by leading to upregulation of LDLR expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor; could possibly inhibit ST7 by impacting DNA methylation patterns, influencing gene expression profiles associated with its activity.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$252.00
$495.00
9
(1)

Atorvastatin acts similarly to Simvastatin by inhibiting HMG-CoA reductase. This could possibly inhibit ST7 function by influencing LDLR expression.

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$28.00
$88.00
$332.00
12
(1)

Lovastatin is another statin that can inhibit HMG-CoA reductase. This could possibly inhibit ST7 function by influencing LDLR expression.

Rosuvastatin

287714-41-4sc-481834
10 mg
$142.00
8
(0)

Rosuvastatin, a statin, can also inhibit HMG-CoA reductase. This could possibly inhibit ST7 function by affecting LDLR expression.

Pravastatin, Sodium Salt

81131-70-6sc-203218
sc-203218A
sc-203218B
25 mg
100 mg
1 g
$68.00
$159.00
$772.00
2
(1)

Pravastatin is a statin that can inhibit HMG-CoA reductase. This could possibly inhibit ST7 function by influencing LDLR expression.

RGFP966

1357389-11-7sc-507300
5 mg
$115.00
(0)

Selective HDAC3 inhibitor; could possibly inhibit ST7 by influencing chromatin structure, affecting related gene expression.

Fluvastatin

93957-54-1sc-279169
50 mg
$250.00
(0)

Fluvastatin, another statin, can inhibit HMG-CoA reductase. This could possibly inhibit ST7 function by affecting LDLR expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Antitumor antibiotic; binds to DNA and could possibly inhibit ST7 by interfering with transcriptional processes related to its tumor suppressive role.